Table 3.

Demographic, fasting lipid profile and PON1 status of healthy controls and patients with liver diseases

	Healthy controls (n=53)	Acute viral hepatitis (n=14)	Cirrhosis with portal hypertension (n=33)	Leptospirosis (n=14)	Sepsis (n=15)	Left ventricular failure (n=9)	Falciparum malaria (n=10)
Age (years)	34±12	47±11	39±9	39±6	35±8	36±11	34±7
Sex (M/F)	31/22	9/5	19/14	6/8	11/4	6/3	6/4
TC (mg/dL)	154.5±16.27	137±72.57	97.65±56.63**	124.41±49.75	143.54±91.66	78.15±30.9*	101.14±13.71
HDLC (mg/dL)	50.14±4.21	68.5±75.7	11.27±13.66**	6.6±5.06**	23.16±13.6*	4.8±1.7**	7.84±6.21**
TAG (mg/dL)	70.02±13.23	130.13±130	97.13±91.6	176.34±87**	136.61±63.67	130.52±86.2	318.37±126.59**
LDLC (mg/dL)	90.8±14.57	124.5±90.24	80.33±61.98	76.44±32.29	135.53±121.7	64.65±24.47	74.35±21.86
RATIO (mg/dL)	3.07±0.38	5.06±4.29	10.59±6.34**	8.44±4.52**	9.46±2.74**	9.8±3.17**	6.32±2.07
PON1 (mg/dL)	141.97±8.27	58.6±22.34**	126.47±104.87	86.8±32.43	53.76±25.81**	134.45±102	76.16±27.83*

^**P<0.001 compared to normal controls

^*P<0.05 compared to normal controls; Data expressed as mean±SD